flumazenil has been researched along with tridemorph in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castiglia, D; Charlesworth, A; Has, C; Hatvani, Z; Kárpáti, S; Mayer, B; Mazán, M; Medvecz, M; Pamjav, H; Petit, F; Pintér, D; Silló, P | 1 |
1 other study(ies) available for flumazenil and tridemorph
Article | Year |
---|---|
A unique LAMB3 splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries.
Topics: Amino Acid Substitution; Cell Adhesion Molecules; DNA, Complementary; Emigration and Immigration; Epidermolysis Bullosa, Junctional; Female; Founder Effect; France; Genome, Human; Germany; Haplotypes; Humans; Hungary; Infant; Italy; Kalinin; Male; Mutation; Phylogeography; Polymorphism, Single Nucleotide; RNA; RNA Splice Sites; Roma | 2016 |